Home / Inspections / 954842

FDA Inspection 954842 — Centrient Pharmaceuticals India Private Limited

Centrient Pharmaceuticals India Private Limited — FEI 3004497364

The FDA completed an inspection of Centrient Pharmaceuticals India Private Limited on December 18, 2015 in Nawashahr. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 18, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nawashahr (India)

Facility

Other inspections at this facility

  • 1310126 (OAI Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1175790 (OAI Fri Jul 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1050153 (OAI Fri Apr 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources